Mutations occur in any of the RAS genes (NRAS > HRAS > KRAS in nodules/tumors of follicular cells, HRAS > KRAS > NRAS in medullary carcinoma). This evidence concerns the gene HRAS and medullary thyroid gland carcinoma.